{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:51:20Z","timestamp":1791924680752,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002653","name":"Yorkshire Cancer Research (GB)","doi-asserted-by":"publisher","award":["LOO2 PH"],"award-info":[{"award-number":["LOO2 PH"]}],"id":[{"id":"10.13039\/501100002653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12943-015-0477-z","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T19:01:10Z","timestamp":1449601270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas"],"prefix":"10.1186","volume":"14","author":[{"given":"S.","family":"Kreuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. B.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Tooze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-3546","authenticated-orcid":false,"given":"P. F.","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"issue":"24","key":"477_CR1","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79(24):7824\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"477_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpedsurg.2005.10.025","volume":"41","author":"I Gomez-Curet","year":"2006","unstructured":"Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ. c-Myc inhibition negatively impacts lymphoma growth. J Pediatr Surg. 2006;41(1):207. doi: 10.1016\/j.jpedsurg.2005.10.025 .","journal-title":"J Pediatr Surg"},{"issue":"3","key":"477_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/1541-7786.MCR-11-0394","volume":"10","author":"LC Spender","year":"2012","unstructured":"Spender LC, Inman GJ. Phosphoinositide 3-kinase\/AKT\/mTORC1\/2 signaling determines sensitivity of Burkitt\u2019s lymphoma cells to BH3 mimetics. Mol Cancer Res. 2012;10(3):347\u201359. doi: 10.1158\/1541-7786.MCR-11-0394 .","journal-title":"Mol Cancer Res"},{"issue":"9844","key":"477_CR4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380(9844):848\u201357. doi: 10.1016\/S0140-6736(12)60605-9 .","journal-title":"Lancet"},{"issue":"6769","key":"477_CR5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311. doi: 10.1038\/35000501 .","journal-title":"Nature"},{"issue":"25","key":"477_CR6","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937\u201347. doi: 10.1056\/NEJMoa012914 .","journal-title":"N Engl J Med"},{"issue":"17","key":"477_CR7","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100(17):9991\u20136. doi: 10.1073\/pnas.1732008100 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"477_CR8","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","volume":"21","author":"J Iqbal","year":"2007","unstructured":"Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 2007;21(11):2332\u201343. doi: 10.1038\/sj.leu.2404856 .","journal-title":"Leukemia"},{"issue":"1","key":"477_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ccr.2013.12.012","volume":"25","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Dalla-Favera R. SnapShot: diffuse large B cell lymphoma. Cancer Cell. 2014;25(1):132\u20131320. doi: 10.1016\/j.ccr.2013.12.012 .","journal-title":"Cancer Cell"},{"issue":"2","key":"477_CR10","doi-asserted-by":"crossref","first-page":"e55895","DOI":"10.1371\/journal.pone.0055895","volume":"8","author":"MA Care","year":"2013","unstructured":"Care MA, Barrans S, Worrillow L, Jack A, Westhead DR, Tooze RM. A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma. PLoS One. 2013;8(2):e55895. doi: 10.1371\/journal.pone.0055895 .","journal-title":"PLoS One"},{"issue":"3","key":"477_CR11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/bjc.2012.272","volume":"107","author":"L Brault","year":"2012","unstructured":"Brault L, Menter T, Obermann EC, Knapp S, Thommen S, Schwaller J, et al. PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. Br J Cancer. 2012;107(3):491\u2013500. doi: 10.1038\/bjc.2012.272 .","journal-title":"Br J Cancer"},{"issue":"20","key":"477_CR12","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1182\/blood-2011-03-344374","volume":"118","author":"C Gomez-Abad","year":"2011","unstructured":"Gomez-Abad C, Pisonero H, Blanco-Aparicio C, Roncador G, Gonzalez-Menchen A, Martinez-Climent JA, et al. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood. 2011;118(20):5517\u201327. doi: 10.1182\/blood-2011-03-344374 .","journal-title":"Blood"},{"issue":"4","key":"477_CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(89)90589-8","volume":"56","author":"M Lohuizen van","year":"1989","unstructured":"van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T, et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 1989;56(4):673\u201382.","journal-title":"Cell"},{"issue":"2","key":"477_CR14","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/MCB.11.2.1176","volume":"11","author":"S Verbeek","year":"1991","unstructured":"Verbeek S, van Lohuizen M, van der Valk M, Domen J, Kraal G, Berns A. Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol. 1991;11(2):1176\u20139.","journal-title":"Mol Cell Biol"},{"issue":"17","key":"477_CR15","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/onc.2010.10","volume":"29","author":"J Wang","year":"2010","unstructured":"Wang J, Kim J, Roh M, Franco OE, Hayward SW, Wills ML, et al. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene. 2010;29(17):2477\u201387. doi: 10.1038\/onc.2010.10 .","journal-title":"Oncogene"},{"issue":"14","key":"477_CR16","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/onc.2011.371","volume":"31","author":"J Wang","year":"2012","unstructured":"Wang J, Anderson PD, Luo W, Gius D, Roh M, Abdulkadir SA. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Oncogene. 2012;31(14):1794\u2013803. doi: 10.1038\/onc.2011.371 .","journal-title":"Oncogene"},{"issue":"7","key":"477_CR17","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1074\/jbc.M409123200","volume":"280","author":"KC Qian","year":"2005","unstructured":"Qian KC, Wang L, Hickey ER, Studts J, Barringer K, Peng C, et al. Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem. 2005;280(7):6130\u20137. doi: 10.1074\/jbc.M409123200 .","journal-title":"J Biol Chem"},{"issue":"6228","key":"477_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/340061a0","volume":"340","author":"M Breuer","year":"1989","unstructured":"Breuer M, Slebos R, Verbeek S, van Lohuizen M, Wientjens E, Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature. 1989;340(6228):61\u20133. doi: 10.1038\/340061a0 .","journal-title":"Nature"},{"issue":"1","key":"477_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0092-8674(84)90309-X","volume":"37","author":"HT Cuypers","year":"1984","unstructured":"Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell. 1984;37(1):141\u201350. doi: 10.1016\/0092-8674(84)90309-X .","journal-title":"Cell"},{"issue":"8","key":"477_CR20","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2002-06-1677","volume":"101","author":"M Mizuki","year":"2003","unstructured":"Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, et al. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood. 2003;101(8):3164\u201373. doi: 10.1182\/blood-2002-06-1677 .","journal-title":"Blood"},{"issue":"5","key":"477_CR21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/10428190310001641251","volume":"45","author":"AM Cohen","year":"2004","unstructured":"Cohen AM, Grinblat B, Bessler H, Kristt D, Kremer A, Schwartz A, et al. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma. 2004;45(5):951\u20135. doi: 10.1080\/10428190310001641251 .","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"477_CR22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jcp.2005.027672","volume":"59","author":"TL Cibull","year":"2006","unstructured":"Cibull TL, Jones TD, Li L, Eble JN, Ann Baldridge L, Malott SR, et al. Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol. 2006;59(3):285\u20138. doi: 10.1136\/jcp.2005.027672 .","journal-title":"J Clin Pathol"},{"issue":"6849","key":"477_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35090585","volume":"412","author":"SM Dhanasekaran","year":"2001","unstructured":"Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412(6849):822\u20136. doi: 10.1038\/35090585 .","journal-title":"Nature"},{"issue":"3","key":"477_CR24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2006.04.110","volume":"345","author":"LA Gapter","year":"2006","unstructured":"Gapter LA, Magnuson NS, Ng K-yY, Hosick HL. Pim-1 kinase expression during murine mammary development. Biochem Biophys Res Commun. 2006;345(3):989\u201397. doi: 10.1016\/j.bbrc.2006.04.110 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"477_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mce.2012.10.028","volume":"365","author":"M Malinen","year":"2013","unstructured":"Malinen M, J\u00e4\u00e4skel\u00e4inen T, Pelkonen M, Heikkinen S, V\u00e4is\u00e4nen S, Kosma V-MM, et al. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors. Mol Cell Endocrinol. 2013;365(2):270\u20136. doi: 10.1016\/j.mce.2012.10.028 .","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"477_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1593\/neo.81038","volume":"11","author":"K Peltola","year":"2009","unstructured":"Peltola K, Hollmen M, Maula S-MM, Rainio E, Ristam\u00e4ki R, Luukkaa M, et al. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia. 2009;11(7):629\u201336.","journal-title":"Neoplasia"},{"issue":"9","key":"477_CR27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cbt.7.9.6418","volume":"7","author":"C Reiser-Erkan","year":"2008","unstructured":"Reiser-Erkan C, Erkan M, Pan Z, Bekasi S, Giese NA, Streit S, et al. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2008;7(9):1352\u20139.","journal-title":"Cancer Biol Ther"},{"key":"477_CR28","doi-asserted-by":"crossref","unstructured":"Jin Y, Tong D-yY, Chen J-nN, Feng Z-yY, Yang J-yY, Shao C-kK et al. Overexpression of osteopontin, \u03b1v\u03b23 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer. PloS one. 2012;7(10). doi: 10.1371\/journal.pone.0048575 .","DOI":"10.1371\/journal.pone.0048575"},{"issue":"5","key":"477_CR29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cell.2010.01.003","volume":"140","author":"AD Goldberg","year":"2010","unstructured":"Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell. 2010;140(5):678\u201391. doi: 10.1016\/j.cell.2010.01.003 .","journal-title":"Cell"},{"issue":"3","key":"477_CR30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/pros.20294","volume":"65","author":"H Dai","year":"2005","unstructured":"Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, Tahir S, et al. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate. 2005;65(3):276\u201386. doi: 10.1002\/pros.20294 .","journal-title":"Prostate"},{"issue":"1","key":"477_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jss.2008.03.033","volume":"153","author":"J Gong","year":"2009","unstructured":"Gong J, Wang J, Ren K, Liu C, Li B, Shi Y. Serine\/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell. J Surg Res. 2009;153(1):17\u201322. doi: 10.1016\/j.jss.2008.03.033 .","journal-title":"J Surg Res"},{"issue":"8","key":"477_CR32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ncb1618","volume":"9","author":"A Zippo","year":"2007","unstructured":"Zippo A, De Robertis A, Serafini R, Oliviero S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol. 2007;9(8):932\u201344. doi: 10.1038\/ncb1618 .","journal-title":"Nat Cell Biol"},{"issue":"6","key":"477_CR33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2009.07.031","volume":"138","author":"A Zippo","year":"2009","unstructured":"Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell. 2009;138(6):1122\u201336. doi: 10.1016\/j.cell.2009.07.031 .","journal-title":"Cell"},{"key":"477_CR34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2407-10-248","volume":"10","author":"J Kim","year":"2010","unstructured":"Kim J, Roh M, Abdulkadir SA. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. BMC Cancer. 2010;10:248. doi: 10.1186\/1471-2407-10-248 .","journal-title":"BMC Cancer"},{"issue":"1A","key":"477_CR35","first-page":"167","volume":"23","author":"Y Ionov","year":"2003","unstructured":"Ionov Y, Le X, Tunquist BJ, Sweetenham J, Sachs T, Ryder J, et al. Pim-1 protein kinase is nuclear in Burkitt\u2019s lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res. 2003;23(1A):167\u201378.","journal-title":"Anticancer Res"},{"issue":"22","key":"477_CR36","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1158\/0008-5472.CAN-04-2284","volume":"64","author":"PS Hammerman","year":"2004","unstructured":"Hammerman PS, Fox CJ, Cinalli RM, Xu A, Wagner JD, Lindsten T, et al. Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation. Cancer Res. 2004;64(22):8341\u20138. doi: 10.1158\/0008-5472.CAN-04-2284 .","journal-title":"Cancer Res"},{"issue":"35","key":"477_CR37","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/onc.2008.123","volume":"27","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Wang Z, Li X, Magnuson NS. Pim kinase-dependent inhibition of c-Myc degradation. Oncogene. 2008;27(35):4809\u201319. doi: 10.1038\/onc.2008.123 .","journal-title":"Oncogene"},{"issue":"1\u20133","key":"477_CR38","first-page":"43","volume":"571","author":"TL Aho","year":"2004","unstructured":"Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett. 2004;571(1\u20133):43\u20139. doi: 10.1016\/j.febslet.2004.06.050 .","journal-title":"FEBS Lett"},{"key":"477_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-7-1","volume":"7","author":"A Macdonald","year":"2006","unstructured":"Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JS. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol. 2006;7:1. doi: 10.1186\/1471-2121-7-1 .","journal-title":"BMC Cell Biol"},{"issue":"48","key":"477_CR40","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/onc.2009.276","volume":"28","author":"JJ Gu","year":"2009","unstructured":"Gu JJ, Wang Z, Reeves R, Magnuson NS. PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene. 2009;28(48):4261\u201371. doi: 10.1038\/onc.2009.276 .","journal-title":"Oncogene"},{"issue":"11","key":"477_CR41","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2004-09-3706","volume":"105","author":"PS Hammerman","year":"2005","unstructured":"Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood. 2005;105(11):4477\u201383. doi: 10.1182\/blood-2004-09-3706 .","journal-title":"Blood"},{"issue":"23","key":"477_CR42","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.4161\/cc.8.23.10091","volume":"8","author":"J Tamburini","year":"2009","unstructured":"Tamburini J, Green AS, Chapuis N, Bardet V, Lacombe C, Mayeux P, et al. Targeting translation in acute myeloid leukemia: a new paradigm for therapy? Cell Cycle. 2009;8(23):3893\u20139.","journal-title":"Cell Cycle"},{"issue":"46","key":"477_CR43","doi-asserted-by":"crossref","first-page":"48319","DOI":"10.1074\/jbc.M404440200","volume":"279","author":"M Bachmann","year":"2004","unstructured":"Bachmann M, Hennemann H, Xing PX, Hoffmann I, M\u00f6r\u00f6y T. The oncogenic serine\/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2\/M cell cycle checkpoint. J Biol Chem. 2004;279(46):48319\u201328. doi: 10.1074\/jbc.M404440200 .","journal-title":"J Biol Chem"},{"issue":"26","key":"477_CR44","doi-asserted-by":"crossref","first-page":"18659","DOI":"10.1074\/jbc.274.26.18659","volume":"274","author":"T Mochizuki","year":"1999","unstructured":"Mochizuki T, Kitanaka C, Noguchi K, Muramatsu T, Asai A, Kuchino Y. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem. 1999;274(26):18659\u201366. doi: 10.1074\/jbc.274.26.18659 .","journal-title":"J Biol Chem"},{"issue":"3","key":"477_CR45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biocel.2005.10.010","volume":"38","author":"M Bachmann","year":"2006","unstructured":"Bachmann M, Kosan C, Xing PX, Montenarh M, Hoffmann I, M\u00f6r\u00f6y T. The oncogenic serine\/threonine kinase Pim-1 directly phosphorylates and activates the G2\/M specific phosphatase Cdc25C. Int J Biochem Cell Biol. 2006;38(3):430\u201343. doi: 10.1016\/j.biocel.2005.10.010 .","journal-title":"Int J Biochem Cell Biol"},{"issue":"13","key":"477_CR46","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-08-0634","volume":"68","author":"D Morishita","year":"2008","unstructured":"Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res. 2008;68(13):5076\u201385. doi: 10.1158\/0008-5472.CAN-08-0634 .","journal-title":"Cancer Res"},{"issue":"39","key":"477_CR47","doi-asserted-by":"crossref","first-page":"36671","DOI":"10.1074\/jbc.M203213200","volume":"277","author":"Z You","year":"2002","unstructured":"You Z, Madrid LV, Saims D, Sedivy J, Wang CY. c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation. J Biol Chem. 2002;277(39):36671\u20137. doi: 10.1074\/jbc.M203213200 .","journal-title":"J Biol Chem"},{"issue":"9","key":"477_CR48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1541-7786.MCR-06-0388","volume":"5","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Wang Z, Magnuson NS. Pim-1 kinase-dependent phosphorylation of p21Cip1\/WAF1 regulates its stability and cellular localization in H1299 cells. Mol Cancer Res. 2007;5(9):909\u201322. doi: 10.1158\/1541-7786.MCR-06-0388 .","journal-title":"Mol Cancer Res"},{"issue":"38","key":"477_CR49","doi-asserted-by":"crossref","first-page":"29128","DOI":"10.1074\/jbc.M110.137240","volume":"285","author":"B Cen","year":"2010","unstructured":"Cen B, Mahajan S, Zemskova M, Beharry Z, Lin Y-WW, Cramer SD, et al. Regulation of Skp2 levels by the Pim-1 protein kinase. J Biol Chem. 2010;285(38):29128\u201337. doi: 10.1074\/jbc.M110.137240 .","journal-title":"J Biol Chem"},{"issue":"11","key":"477_CR50","doi-asserted-by":"crossref","first-page":"e26837","DOI":"10.1371\/journal.pone.0026837","volume":"6","author":"V Seitz","year":"2011","unstructured":"Seitz V, Butzhammer P, Hirsch B, Hecht J, Gutgemann I, Ehlers A, et al. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One. 2011;6(11):e26837. doi: 10.1371\/journal.pone.0026837 .","journal-title":"PLoS One"},{"issue":"6","key":"477_CR51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","volume":"123","author":"EK Keeton","year":"2014","unstructured":"Keeton EK, McEachern K, Dillman KS, Palakurthi S, Cao Y, Grondine MR, et al. AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. Blood. 2014;123(6):905\u201313. doi: 10.1182\/blood-2013-04-495366 .","journal-title":"Blood"},{"issue":"6","key":"477_CR52","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1535-7163.MCT-13-0722","volume":"13","author":"Q Guo","year":"2014","unstructured":"Guo Q, Lan P, Yu X, Han Q, Zhang J, Tian Z, et al. Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects. Mol Cancer Ther. 2014;13(6):1503\u201313. doi: 10.1158\/1535-7163.MCT-13-0722 .","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"477_CR53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.molcel.2011.03.022","volume":"42","author":"S Baek","year":"2011","unstructured":"Baek S. When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell. 2011;42(3):274\u201384. doi: 10.1016\/j.molcel.2011.03.022 .","journal-title":"Mol Cell"},{"issue":"26","key":"477_CR54","doi-asserted-by":"crossref","first-page":"18012","DOI":"10.1074\/jbc.M709695200","volume":"283","author":"C Hogan","year":"2008","unstructured":"Hogan C, Hutchison C, Marcar L, Milne D, Saville M, Goodlad J, et al. Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma. J Biol Chem. 2008;283(26):18012\u201323. doi: 10.1074\/jbc.M709695200 .","journal-title":"J Biol Chem"},{"issue":"51","key":"477_CR55","doi-asserted-by":"crossref","first-page":"35403","DOI":"10.1074\/jbc.M109.059501","volume":"284","author":"U Maitra","year":"2009","unstructured":"Maitra U, Singh N, Gan L, Ringwood L, Li L. IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes. J Biol Chem. 2009;284(51):35403\u201311. doi: 10.1074\/jbc.M109.059501 .","journal-title":"J Biol Chem"},{"issue":"1","key":"477_CR56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jmb.2005.02.039","volume":"348","author":"A Kumar","year":"2005","unstructured":"Kumar A, Mandiyan V, Suzuki Y, Zhang C, Rice J, Tsai J, et al. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma. J Mol Biol. 2005;348(1):183\u201393. doi: 10.1016\/j.jmb.2005.02.039 .","journal-title":"J Mol Biol"},{"issue":"7152","key":"477_CR57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature05953","volume":"448","author":"D Dominguez-Sola","year":"2007","unstructured":"Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, et al. Non-transcriptional control of DNA replication by c-Myc. Nature. 2007;448(7152):445\u201351. doi: 10.1038\/nature05953 .","journal-title":"Nature"},{"issue":"1","key":"477_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molcel.2008.07.023","volume":"32","author":"P Lefevre","year":"2008","unstructured":"Lefevre P, Witham J, Lacroix CE, Cockerill PN, Bonifer C. The LPS-induced transcriptional upregulation of the chicken lysozyme locus involves CTCF eviction and noncoding RNA transcription. Mol Cell. 2008;32(1):129\u201339. doi: 10.1016\/j.molcel.2008.07.023 .","journal-title":"Mol Cell"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-015-0477-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T21:11:06Z","timestamp":1498252266000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-015-0477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s12943-015-0477-z","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"205"}}